Avadel Pharmaceuticals (FRA:AWK) FCF Margin % : 15.62% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Avadel Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avadel Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2024 was €7.5 Mil. Avadel Pharmaceuticals's Revenue for the three months ended in Dec. 2024 was €48.1 Mil. Therefore, Avadel Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 15.62%.

As of today, Avadel Pharmaceuticals's current FCF Yield % is -6.10%.

The historical rank and industry rank for Avadel Pharmaceuticals's FCF Margin % or its related term are showing as below:

FRA:AWK' s FCF Margin % Range Over the Past 10 Years
Min: -459.58 Med: -46.26 Max: 47.78
Current: -27.37

During the past 13 years, the highest FCF Margin % of Avadel Pharmaceuticals was 47.78%. The lowest was -459.58%. And the median was -46.26%.

FRA:AWK's FCF Margin % is ranked worse than
83.4% of 970 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs FRA:AWK: -27.37

Avadel Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Avadel Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avadel Pharmaceuticals FCF Margin % Chart

Avadel Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-218.64

-459.58

-27.74

Avadel Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-144.09	-109.29	-43.82	-13.77	15.62

Competitive Comparison of Avadel Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Avadel Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avadel Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avadel Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avadel Pharmaceuticals's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Avadel Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avadel Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-44.796	/	161.507
	=	-27.74 %

Avadel Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	7.519	/	48.142
	=	15.62 %

Avadel Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Avadel Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avadel Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avadel Pharmaceuticals PLC (FRA:AWK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AVDL:USA

Address

10 Earlsfort Terrace, Dublin 2, Dublin, IRL, D02 T380

Website

https://www.avadel.com

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.